Vasculitis: Difference between revisions
imported>Robert Badgett m (→Classification) |
imported>Robert Badgett |
||
| Line 32: | Line 32: | ||
Affect the "dermal venules, mucosal arterioles, glomerular capillaries, and pulmonary alveolar capillaries."<ref name="pmid9366584">{{cite journal |author=Jennette JC, Falk RJ |title=Small-vessel vasculitis |journal=N. Engl. J. Med. |volume=337 |issue=21 |pages=1512-23 |year=1997 |pmid=9366584 |doi=|url=http://content.nejm.org/cgi/content/full/337/21/1512}}</ref> | Affect the "dermal venules, mucosal arterioles, glomerular capillaries, and pulmonary alveolar capillaries."<ref name="pmid9366584">{{cite journal |author=Jennette JC, Falk RJ |title=Small-vessel vasculitis |journal=N. Engl. J. Med. |volume=337 |issue=21 |pages=1512-23 |year=1997 |pmid=9366584 |doi=|url=http://content.nejm.org/cgi/content/full/337/21/1512}}</ref> | ||
|valign="top"|'''ANCA'''<br/> | |||
[[Antineutrophil cytoplasmic antibody| | [[Antineutrophil cytoplasmic antibody|Antineutrophil cytoplasmic antibodies]] (ANCA) are associated with some small vessel vasculitides including their localized forms such as pauci-immune necrotising and crescentic glomerulonephritis.<ref name="pmid16876669">{{cite journal |author=Bosch X, Guilabert A, Font J |title=Antineutrophil cytoplasmic antibodies |journal=Lancet |volume=368 |issue=9533 |pages=404–18 |year=2006 |pmid=16876669 |doi=10.1016/S0140-6736(06)69114-9}}</ref> | ||
With partial exception from microscopic polyangiitis, these vasculitides are associated with respiratory manifestations.<ref name="pmid9366584"/><ref name="pmid16876669">{{cite journal| author=Bosch X, Guilabert A, Font J| title=Antineutrophil cytoplasmic antibodies. | journal=Lancet | year= 2006 | volume= 368 | issue= 9533 | pages= 404-18 | pmid=16876669 | With partial exception from microscopic polyangiitis, these vasculitides are associated with respiratory manifestations.<ref name="pmid9366584"/><ref name="pmid16876669">{{cite journal| author=Bosch X, Guilabert A, Font J| title=Antineutrophil cytoplasmic antibodies. | journal=Lancet | year= 2006 | volume= 368 | issue= 9533 | pages= 404-18 | pmid=16876669 | ||
| Line 46: | Line 46: | ||
|- | |- | ||
| valign="top"|'''Immune complex'''<br/> | |||
These vasculitides are associated with [[immune complex]]es. With partial exception from microscopic polyangiitis, are associated with dermatological manifestations.<ref name="pmid9366584">{{cite journal| author=Jennette JC, Falk RJ| title=Small-vessel vasculitis. | journal=N Engl J Med | year= 1997 | volume= 337 | issue= 21 | pages= 1512-23 | pmid=9366584 | These vasculitides are associated with [[immune complex]]es. With partial exception from microscopic polyangiitis, are associated with dermatological manifestations.<ref name="pmid9366584">{{cite journal| author=Jennette JC, Falk RJ| title=Small-vessel vasculitis. | journal=N Engl J Med | year= 1997 | volume= 337 | issue= 21 | pages= 1512-23 | pmid=9366584 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&email=badgett@uthscdsa.edu&retmode=ref&cmd=prlinks&id=9366584 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref> | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&email=badgett@uthscdsa.edu&retmode=ref&cmd=prlinks&id=9366584 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref> | ||
|| '''[[Henoch-Schonlein purpura]]'''. Systemic vasculitis due to tissue deposition of IgA-containing immune complexes | || '''[[Henoch-Schonlein purpura]]'''. Systemic vasculitis due to tissue deposition of IgA-containing immune complexes. This is the most common vasculitis in children. | ||
'''[[Hypersensitivity vasculitis]]'''. Usually due to a hypersensitivity reaction to a known drug. There is presence of skin vaculitis with palpable petechiae or purpura. | '''[[Hypersensitivity vasculitis]]'''. Usually due to a hypersensitivity reaction to a known drug. There is presence of skin vaculitis termed [[leukocytoclastic vasculitis]] with palpable petechiae or purpura. Most prominent in postcapillary venules. Serum levels of [[complement system protein]]s may be low. | ||
'''[[Essential cryoglobulinemic vasculitis]]'''. Most often due to | '''[[Essential cryoglobulinemic vasculitis]]'''. Most often due to [[hepatitis C]] infection, immune complexes of cryoglobulins. Serum levels of [[complement system protein]]s may be low. | ||
'''Vasculitis secondary to connective tissue disorders'''. Usually secondary to [[lupus erythematosus| systemic lupus erythematosus]] (SLE), [[rheumatoid arthritis]] (RA), relapsing [[polychondritis]], [[Behcet's Syndrome]], and other connective tissue disorders. | '''Vasculitis secondary to connective tissue disorders'''. Usually secondary to [[lupus erythematosus| systemic lupus erythematosus]] (SLE), [[rheumatoid arthritis]] (RA), relapsing [[polychondritis]], [[Behcet's Syndrome]], and other connective tissue disorders. | ||
'''Vasculitis secondary to viral infection'''. Usually due to hepatitis B and C, HIV, cytomegalovirus, Epstein | '''Vasculitis secondary to viral infection'''. Usually due to [[hepatitis B virus]] and [[hepatitis C virus]], [[Human Immunodeficiency Virus Type 1]] (HIV), [[cytomegalovirus]], [[Epstein Barr virus]], and [[Parvovirus B19]]. | ||
|| | |||
|} | |||
==Treatment== | ==Treatment== | ||
Revision as of 12:10, 26 February 2010
Vasculitis is a general term for inflammation of blood vessel walls. Most vasculitides are autoimmune diseases and the treatment involves immunosuppression or immunomodulation.
Classification
Vasculitides can be classified by the size of the blood vessel that they predominantly affect.[1] The following is based on Table 1 and Table 2 of Jennette.[2]
| Examples | |||
|---|---|---|---|
| Large vessel[3] Associated with Type IV, cellular (delayed), hypersensitivity. |
Takayasu arteritis. Primarily affects the aorta and its main branches. Patients are usually less than 50 years old. May be associated with anti-endothelial cell antibody.
Giant cell (temporal) arteritis. Chronic vasculitis of both large and medium vessels, primarily affecting cranial branches of the arteries arising from the aortic arch. Patients are usually over 50 years old. |
||
| Medium vessel[3] |
Polyarteritis nodosa. Systemic necrotizing vasculitis and aneurysm formation with sparing of the lungs and glomeruli. Blood tests for autoimmunity are usually normal; however, tests for inflammation (such as the erythrocyte sedimentation rate) may be abnormal.
Kawasaki disease. Affects vessels of all sizes especially the coronary arteries. Usually in children and is associated with a mucocutaneous lymph node syndrome. Thromboangiitis obliterans Buerger's disease. Blood tests for inflammation (including the ) and autoimmunity are usually normal. Isolated CNS vasculitis. Affects medium and small arteries over a diffuse CNS area, without symptomatic extracranial vessel involvement. Patients have CNS symptoms as well as cerebral vasculitis by angiography and leptomeningeal biopsy. |
||
| Small vessel[2] Associated with Type III, immediate hypersensitivity. |
ANCA Antineutrophil cytoplasmic antibodies (ANCA) are associated with some small vessel vasculitides including their localized forms such as pauci-immune necrotising and crescentic glomerulonephritis.[5] With partial exception from microscopic polyangiitis, these vasculitides are associated with respiratory manifestations.[2][5] |
Wegener's granulomatosis. Systemic vasculitis of medium and small arteries, including venules and arterioles. Produces granulomatous inflammation of the respiratory tracts and necrotizing, pauci-immune glomerulonephritis. Most common cause of saddle nose deformity in USA (nose flattened due to destruction of nasal septum by granulomatous inflammation). Almost all patients with Wegener's have c-ANCA, but not vice versa.
Churg-Strauss arteritis. Affects medium and small vessels with vascular and extravascular granulomatosis. Classically involves arteries of lungs and skin, but may be generalized. The triad asthma, eczema and renal abnormalities (e.g., red blood cell casts in urine) should raise suspicion, calling for an eosinophil count. Eosinophilia, with this clinical presentation, is grounds for a preliminary diagnosis, but immunologic confirmation is needed. Microscopic polyarteritis/polyangiitis. Affects capillaries, venules, or arterioles. Thought to be part of a group that includes Wegener's since both are associated with ANCA and similar extrapulmonary manifestations. Patients do not usually have symptomatic or histologic respiratory involvement.[5] |
Treatment depends on whether the goal is to induce remission or maintenance and depends on severity of the vasculitis.[6] |
| Immune complex These vasculitides are associated with immune complexes. With partial exception from microscopic polyangiitis, are associated with dermatological manifestations.[2] |
Henoch-Schonlein purpura. Systemic vasculitis due to tissue deposition of IgA-containing immune complexes. This is the most common vasculitis in children.
Hypersensitivity vasculitis. Usually due to a hypersensitivity reaction to a known drug. There is presence of skin vaculitis termed leukocytoclastic vasculitis with palpable petechiae or purpura. Most prominent in postcapillary venules. Serum levels of complement system proteins may be low. Essential cryoglobulinemic vasculitis. Most often due to hepatitis C infection, immune complexes of cryoglobulins. Serum levels of complement system proteins may be low. Vasculitis secondary to connective tissue disorders. Usually secondary to systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), relapsing polychondritis, Behcet's Syndrome, and other connective tissue disorders. Vasculitis secondary to viral infection. Usually due to hepatitis B virus and hepatitis C virus, Human Immunodeficiency Virus Type 1 (HIV), cytomegalovirus, Epstein Barr virus, and Parvovirus B19. |
||
Treatment
In general, treatment involves immunosuppression, usually starting with corticosteroids but often using cytotoxic agents such as cyclophosphamide or methotrexate as well. Plasmapheresis may be useful. Immunologic therapies are evolving.
References
- ↑ Jennette JC, Falk RJ, Andrassy K, et al (1994). "Nomenclature of systemic vasculitides. Proposal of an international consensus conference". Arthritis Rheum. 37 (2): 187-92. PMID 8129773. [e]
- ↑ 2.0 2.1 2.2 2.3 2.4 Jennette JC, Falk RJ (1997). "Small-vessel vasculitis". N. Engl. J. Med. 337 (21): 1512-23. PMID 9366584. [e]
Cite error: Invalid
<ref>tag; name "pmid9366584" defined multiple times with different content Cite error: Invalid<ref>tag; name "pmid9366584" defined multiple times with different content - ↑ 3.0 3.1 3.2 Weyand CM, Goronzy JJ (2003). "Medium- and large-vessel vasculitis". N. Engl. J. Med. 349 (2): 160–9. DOI:10.1056/NEJMra022694. PMID 12853590. Research Blogging.
Cite error: Invalid
<ref>tag; name "pmid12853590" defined multiple times with different content Cite error: Invalid<ref>tag; name "pmid12853590" defined multiple times with different content - ↑ Rabb H, Colvin RB (2007). "Case records of the Massachusetts General Hospital. Case 31-2007. A 41-year-old man with abdominal pain and elevated serum creatinine". N. Engl. J. Med. 357 (15): 1531–41. DOI:10.1056/NEJMcpc079024. PMID 17928602. Research Blogging.
- ↑ 5.0 5.1 5.2 Bosch X, Guilabert A, Font J (2006). "Antineutrophil cytoplasmic antibodies". Lancet 368 (9533): 404–18. DOI:10.1016/S0140-6736(06)69114-9. PMID 16876669. Research Blogging.
Cite error: Invalid
<ref>tag; name "pmid16876669" defined multiple times with different content Cite error: Invalid<ref>tag; name "pmid16876669" defined multiple times with different content - ↑ Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007). "Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review". JAMA 298 (6): 655-69. DOI:10.1001/jama.298.6.655. PMID 17684188. Research Blogging.